Your Infinity Gauntlet of Knowlege.

Coming to a cancer center near you. It’s actually “metric-based Oncology.”

Spoiler alert: The metrics they measure mostly look at limiting costs—no surprise.

Look at tomorrow’s blog posts for more information.

Congress working on bill to further regulate prior-authorizations

It’s hard to get information on the proposal, the bill has been submitted, but it’s just a placeholder for now. There’s not much here but this is the best source I’ve been able to find.

The prior auth process itself is supposed to be streamlined per the SUPPORT Act that was passed last year. The proposed bill apparently will regulate them even more tightly—just another example of the push-back against Medicare Advantage.

UHC Concerned about Medicare-for-All

All the talk has lowered its stock—Medicare Advantage is the only cash-cow it has left.

Most “Medicare for all” proposals would eliminate the private health insurance market—allowing the resources sucked up by these middlemen to be used to actually provide care.

It will never happen, the incumbents have enough money to control the process.

Instead, look for these private companies to administer “Medicare for all.”

Adjusted Mortality Rates Are Lower For Medicare Advantage Than Traditional Medicare, But The Rates Converge Over Time

The money quote:

. . In other words, those initially choosing Medicare Advantage become sicker relative to traditional Medicare beneficiaries over five years. Whether the mortality rates would fully converge if a period longer than five years were observed is a topic for further research.

Keep that in mind whenever you examine research about the benefit of Medicare Advantage.

The real question—does risk-sharing with primes make a long term difference. Anecdotal evidence says yes—big time.

Tomism

Tailored healthcare is more effective across the board than one size fits all—and cheaper, too.

Allow your clinicians the chance to provide it.